{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:20:35Z","timestamp":1757618435148,"version":"3.44.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH","award":["R01CA218436-01"],"award-info":[{"award-number":["R01CA218436-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>A qualitative focus group study was conducted to explore the perceived motivators and barriers to clinical trial participation from the perspective of women at risk for ductal carcinoma in situ (DCIS), women with a history of DCIS, and healthcare providers who care for patients with DCIS to improve recruitment to a prospective multicenter randomized prospective window of opportunity study of a tissue selective estrogen complex in postmenopausal women with DCIS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Qualitative thematic analysis was applied to six online focus groups. The perceived motivators and barriers to participation in DCIS presurgical trials were assessed across groups. Baseline knowledge of DCIS and attitudes toward postmenopausal hormone therapies were also evaluated. Analysis was completed in NVivo.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Potential DCIS pre-surgical trial participants were motivated by altruism, receiving better care, and increased monitoring by the healthcare team. Conversely, the potential for the study drug to cause harm, distrust in the medical field, and the non-life-threatening nature of DCIS were barriers to participation in pre-surgical trial. Healthcare providers felt that participants were motivated by financial incentives and receiving better care. Surgical delays, an ineffective intervention, and participant anxiety were seen as barriers to participation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>There was overlap in the perceived motivators and barriers to participation in a pre-surgical trial among women with a history of DCIS and at-risk women. However, healthcare providers identified differing perceived patient motivators and barriers from these groups, indicating that a greater understanding among health care providers of patient motivators and barriers may facilitate recruitment to DCIS pre-surgical trials.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10549-025-07742-2","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T11:36:00Z","timestamp":1751542560000},"page":"33-42","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Barriers to recruitment in a pre-surgical trial for ductal carcinoma in situ: an exploratory qualitative study of at-risk women, survivors, and providers"],"prefix":"10.1007","volume":"213","author":[{"given":"Elizabeth J.","family":"Adams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Warwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denisha","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Kline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4213-0933","authenticated-orcid":false,"given":"Swati A.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"12","key":"7742_CR1","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1002\/cncr.21069","volume":"103","author":"ME Sanders","year":"2005","unstructured":"Sanders ME, Schuyler PA, Dupont WD, Page DL (2005) The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 103(12):2481\u20132484. https:\/\/doi.org\/10.1002\/cncr.21069","journal-title":"Cancer"},{"issue":"9","key":"7742_CR2","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/cncr.20979","volume":"103","author":"LC Collins","year":"2005","unstructured":"Collins LC, Tamimi RM, Baer HJ, Connolly JL, Colditz GA, Schnitt SJ (2005) Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses\u2019 Health Study. Cancer 103(9):1778\u20131784. https:\/\/doi.org\/10.1002\/cncr.20979","journal-title":"Cancer"},{"issue":"7","key":"7742_CR3","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/1097-0142(19951001)76:7<1197::aid-cncr2820760715>3.0.co;2-0","volume":"76","author":"DL Page","year":"1995","unstructured":"Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA (1995) Continued local recurrence of carcinoma 15\u201325 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 76(7):1197\u20131200. https:\/\/doi.org\/10.1002\/1097-0142(19951001)76:7%3c1197::aid-cncr2820760715%3e3.0.co;2-0","journal-title":"Cancer"},{"issue":"4","key":"7742_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","volume":"121","author":"M van Seijen","year":"2019","unstructured":"van Seijen M, Lips EH, Thompson AM et al (2019) Ductal carcinoma in situ: to treat or not to treat, that is the question. Br J Cancer 121(4):285\u2013292. https:\/\/doi.org\/10.1038\/s41416-019-0478-6","journal-title":"Br J Cancer"},{"issue":"7","key":"7742_CR5","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","volume":"1","author":"SA Narod","year":"2015","unstructured":"Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P (2015) Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol 1(7):888\u2013896. https:\/\/doi.org\/10.1001\/jamaoncol.2015.2510","journal-title":"JAMA Oncol"},{"key":"7742_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/785793","volume":"2015","author":"A Arnaout","year":"2015","unstructured":"Arnaout A, Robertson S, Kuchuk I et al (2015) Evaluating the feasibility of performing window of opportunity trials in breast cancer. Int J Surg Oncol 2015:785793. https:\/\/doi.org\/10.1155\/2015\/785793","journal-title":"Int J Surg Oncol"},{"issue":"1","key":"7742_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10549-022-06611-6","volume":"194","author":"DA Parikh","year":"2022","unstructured":"Parikh DA, Kody L, Brain S et al (2022) Patient perspectives on window of opportunity clinical trials in early-stage breast cancer. Breast Cancer Res Treat 194(1):171\u2013178. https:\/\/doi.org\/10.1007\/s10549-022-06611-6","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"7742_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/cco.0000000000000583","volume":"31","author":"M Arnedos","year":"2019","unstructured":"Arnedos M, Roulleaux Dugage M, Perez-Garcia J, Cortes J (2019) Window of opportunity trials for biomarker discovery in breast cancer. Curr Opin Oncol 31(6):486\u2013492. https:\/\/doi.org\/10.1097\/cco.0000000000000583","journal-title":"Curr Opin Oncol"},{"issue":"5","key":"7742_CR9","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1245\/s10434-021-11169-6","volume":"29","author":"EA Verbus","year":"2022","unstructured":"Verbus EA, Khan TM, Hernandez JM, Kulkarni S (2022) Evaluating the effects of a tissue selective estrogen complex (TSEC) in women with newly diagnosed ductal carcinoma in situ. Ann Surg Oncol 29(5):2769\u20132770. https:\/\/doi.org\/10.1245\/s10434-021-11169-6","journal-title":"Ann Surg Oncol"},{"key":"7742_CR10","volume-title":"Focus groups: a practical guide for applied research","author":"RAC Krueger","year":"2014","unstructured":"Krueger RAC (2014) Focus groups: a practical guide for applied research, vol 5. Sage, Thousand Oaks"},{"key":"7742_CR11","doi-asserted-by":"crossref","unstructured":"Morgan DL Basic and Advanced Focus Groups. 2019. https:\/\/methods.sagepub.com\/book\/basic-and-advanced-focus-groups. Accessed 26 June 2023","DOI":"10.4135\/9781071814307"},{"key":"7742_CR12","volume-title":"Handbook of qualitative research","author":"GRB Ryan","year":"2000","unstructured":"Ryan GRB (2000) Data management and analysis methods. In: Denzin NLY (ed) Handbook of qualitative research. Sage Publications, Thousand Oaks"},{"key":"7742_CR13","doi-asserted-by":"crossref","unstructured":"Katz-Buonincontro J (2022) How to interview and conduct focus groups. APA.","DOI":"10.1037\/0000299-000"},{"key":"7742_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2021.114523","volume":"292","author":"M Hennink","year":"2022","unstructured":"Hennink M, Kaiser BN (2022) Sample sizes for saturation in qualitative research: a systematic review of empirical tests. Soc Sci Med 292:114523. https:\/\/doi.org\/10.1016\/j.socscimed.2021.114523","journal-title":"Soc Sci Med"},{"issue":"9","key":"7742_CR15","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"HF Hsieh","year":"2005","unstructured":"Hsieh HF, Shannon SE (2005) Three approaches to qualitative content analysis. Qual Health Res 15(9):1277\u20131288. https:\/\/doi.org\/10.1177\/1049732305276687","journal-title":"Qual Health Res"},{"issue":"3","key":"7742_CR16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.pec.2011.01.005","volume":"82","author":"F Moretti","year":"2011","unstructured":"Moretti F, van Vliet L, Bensing J et al (2011) A standardized approach to qualitative content analysis of focus group discussions from different countries. Patient Educ Couns 82(3):420\u2013428. https:\/\/doi.org\/10.1016\/j.pec.2011.01.005","journal-title":"Patient Educ Couns"},{"issue":"4","key":"7742_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1158\/1940-6207.Capr-18-0435","volume":"12","author":"G Samimi","year":"2019","unstructured":"Samimi G, Heckman-Stoddard BM, Kay SS et al (2019) Acceptability of localized cancer risk reduction interventions among individuals at average or high risk for cancer. Cancer Prev Res (Phila) 12(4):271\u2013282. https:\/\/doi.org\/10.1158\/1940-6207.Capr-18-0435","journal-title":"Cancer Prev Res (Phila)"},{"key":"7742_CR18","doi-asserted-by":"crossref","unstructured":"Rogers M (2023) Coding qualitative data. In Varieties of qualitative research methods: selected contextual perspectives. Springer. Pp. 73\u201378.","DOI":"10.1007\/978-3-031-04394-9_12"},{"issue":"3","key":"7742_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 22(3):276\u2013282","journal-title":"Biochem Med (Zagreb)"},{"issue":"3","key":"7742_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1369-7625.2008.00498.x","volume":"11","author":"I Juraskova","year":"2008","unstructured":"Juraskova I, Butow P, Lopez A et al (2008) Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS). Health Expect 11(3):252\u2013262. https:\/\/doi.org\/10.1111\/j.1369-7625.2008.00498.x","journal-title":"Health Expect"},{"issue":"1","key":"7742_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.2014.144","volume":"111","author":"I Juraskova","year":"2014","unstructured":"Juraskova I, Butow P, Bonner C et al (2014) Improving decision making about clinical trial participation - a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trial. Br J Cancer 111(1):1\u20137. https:\/\/doi.org\/10.1038\/bjc.2014.144","journal-title":"Br J Cancer"},{"issue":"1","key":"7742_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.pec.2010.07.002","volume":"84","author":"S De Morgan","year":"2011","unstructured":"De Morgan S, Redman S, D\u2019Este C, Rogers K (2011) Knowledge, satisfaction with information, decisional conflict and psychological morbidity amongst women diagnosed with ductal carcinoma in situ (DCIS). Patient Educ Couns 84(1):62\u201368. https:\/\/doi.org\/10.1016\/j.pec.2010.07.002","journal-title":"Patient Educ Couns"},{"issue":"5","key":"7742_CR23","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s12282-017-0765-0","volume":"24","author":"R Mercieca-Bebber","year":"2017","unstructured":"Mercieca-Bebber R, King MT, Boxer MM et al (2017) What quality-of-life issues do women with ductal carcinoma in situ (DCIS) consider important when making treatment decisions? Breast Cancer 24(5):720\u2013729. https:\/\/doi.org\/10.1007\/s12282-017-0765-0","journal-title":"Breast Cancer"},{"issue":"3","key":"7742_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3816\/CBC.2008.n.032","volume":"8","author":"A Partridge","year":"2008","unstructured":"Partridge A, Winer JP, Golshan M et al (2008) Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ. Clin Breast Cancer 8(3):275\u2013280. https:\/\/doi.org\/10.3816\/CBC.2008.n.032","journal-title":"Clin Breast Cancer"},{"issue":"4","key":"7742_CR25","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jamcollsurg.2020.06.021","volume":"231","author":"CA Minami","year":"2020","unstructured":"Minami CA, Kantor O, Weiss A, Nakhlis F, King TA, Mittendorf EA (2020) Association between time to operation and pathologic stage in ductal carcinoma in situ and early-stage hormone receptor-positive breast cancer. J Am Coll Surg 231(4):434-447.e2. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2020.06.021","journal-title":"J Am Coll Surg"},{"key":"7742_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.26698","author":"ES Hwang","year":"2024","unstructured":"Hwang ES, Hyslop T, Lynch T et al (2024) Active monitoring with or without endocrine therapy for low-risk ductal carcinoma in situ: the COMET randomized clinical trial. JAMA. https:\/\/doi.org\/10.1001\/jama.2024.26698","journal-title":"JAMA"},{"key":"7742_CR27","unstructured":"DCIS. 2022. https:\/\/www.youtube.com\/watch?v=3UAHUTZq0WM. DCIS: YouTube."},{"key":"7742_CR28","unstructured":"Dominus S (2023) Women have been Misled about Menopause. The New York Times. 02 Jan 2023. https:\/\/www.nytimes.com\/2023\/02\/01\/magazine\/menopause-hot-flashes-hormone-therapy.html"},{"issue":"1","key":"7742_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/13697130500062654","volume":"8","author":"DL Buick","year":"2005","unstructured":"Buick DL, Crook D, Horne R (2005) Women\u2019s perceptions of hormone replacement therapy: risks and benefits (1980\u20132002). A literature review. Climacteric 8(1):24\u201335. https:\/\/doi.org\/10.1080\/13697130500062654","journal-title":"Climacteric"},{"issue":"5","key":"7742_CR30","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1177\/1740774511414444","volume":"8","author":"TH Truong","year":"2011","unstructured":"Truong TH, Weeks JC, Cook EF, Joffe S (2011) Altruism among participants in cancer clinical trials. Clin Trials 8(5):616\u2013623. https:\/\/doi.org\/10.1177\/1740774511414444","journal-title":"Clin Trials"},{"key":"7742_CR31","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1186\/s12885-015-1904-7","volume":"15","author":"KE Stuart","year":"2015","unstructured":"Stuart KE, Houssami N, Taylor R, Hayen A, Boyages J (2015) Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis. BMC Cancer 15:890. https:\/\/doi.org\/10.1186\/s12885-015-1904-7","journal-title":"BMC Cancer"},{"issue":"7","key":"7742_CR32","doi-asserted-by":"publisher","first-page":"8767","DOI":"10.1002\/cam4.5622","volume":"12","author":"KA Riggan","year":"2023","unstructured":"Riggan KA, Rousseau A, Halyard M et al (2023) \u201cThere\u2019s not enough studies\u201d: views of black breast and ovarian cancer patients on research participation. Cancer Med 12(7):8767\u20138776. https:\/\/doi.org\/10.1002\/cam4.5622","journal-title":"Cancer Med"},{"issue":"3","key":"7742_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/jnci\/djaa155","volume":"113","author":"JM Unger","year":"2021","unstructured":"Unger JM, Hershman DL, Till C et al (2021) \u201cWhen offered to participate\u201d: a systematic review and meta-analysis of patient agreement to participate in cancer clinical trials. J Natl Cancer Inst 113(3):244\u2013257. https:\/\/doi.org\/10.1093\/jnci\/djaa155","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"7742_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1525\/jer.2011.6.3.31","volume":"6","author":"CR Breitkopf","year":"2011","unstructured":"Breitkopf CR, Loza M, Vincent K, Moench T, Stanberry LR, Rosenthal SL (2011) Perceptions of reimbursement for clinical trial participation. J Empir Res Hum Res Ethics 6(3):31\u201338. https:\/\/doi.org\/10.1525\/jer.2011.6.3.31","journal-title":"J Empir Res Hum Res Ethics"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07742-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07742-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07742-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T00:48:10Z","timestamp":1757206090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07742-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["7742"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07742-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}